Vinva Investment Management LTD Neurocrine Biosciences Inc Transaction History
Vinva Investment Management LTD
- $2.63 Trillion
- Q4 2024
A detailed history of Vinva Investment Management LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Vinva Investment Management LTD holds 13,291 shares of NBIX stock, worth $1.6 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
13,291
Previous 38,540
65.51%
Holding current value
$1.6 Million
Previous $4.43 Billion
58.92%
% of portfolio
0.07%
Previous 0.19%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
654Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.22 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$590 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$364 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$306 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...